Related Experiment Video
Updated: Mar 16, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Pharmacotherapy for Insomnia in Primary Care
Emily Smith1, Puneet Narang2, Manasa Enja3
1Department of Family Medicine, North Memorial Hospital, University of Minnesota, Minneapolis.
Managing insomnia pharmacotherapy in primary care is complex due to comorbidities and time constraints. This article reviews insomnia drug treatments and offers clinical case examples for effective sleep management.
Area of Science:
- Sleep Medicine
- Primary Care Therapeutics
- Clinical Pharmacology
Background:
- Insomnia pharmacotherapy in primary care presents unique challenges.
- Coexisting medical/psychiatric conditions, drug interactions, and habit-forming medication concerns complicate treatment.
- Limited appointment times hinder comprehensive sleep management discussions.
Purpose of the Study:
- To review the literature on pharmacotherapy for insomnia.
- To present clinical vignettes illustrating insomnia management strategies.
- To provide evidence-based treatment options for primary care physicians.
Main Methods:
- Conducted a literature search on insomnia pharmacotherapy.
- Developed 4 clinical vignettes representing common primary care scenarios.
- Outlined corresponding pharmacotherapeutic options for each vignette.
Main Results:
- Literature review synthesized current approaches to insomnia drug treatment.
- Vignettes demonstrated practical application of pharmacotherapy in diverse patient profiles.
- Treatment options addressed safety, efficacy, and patient-specific factors.
Conclusions:
- Effective insomnia pharmacotherapy requires careful consideration of patient factors and potential interactions.
- Clinical vignettes serve as valuable educational tools for primary care providers.
- Evidence-based pharmacologic management can improve sleep outcomes in primary care settings.
More Related Videos
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

